I.L.T.-PHARMA: what changed
What changed
I.L.T.-PHARMA
NACE 43.221, Plumbing work
filed annual accounts (NBB)
Net result for the year
€230,631
2024 · €1,570+€229,062
Equity
€939,798
2024 · €709,167+€230,631
Cash
€666,692
2024 · €268,960+€397,731
Balance sheet total
€2.8m
2024 · €3.5m-€750,536
Largest movements
Assets
- Stocks and contracts -€1.1m
down €1.1m (-72.7%), from €1.5m to €416,547
- Cash +€397,731
up €397,731 (+148%), from €268,960 to €666,692
mainly Stocks and contracts (+€1.1m) and Net result for the year (+€230,631)
- Tangible fixed assets -€64,656
down €64,656 (-3.9%), from €1.7m to €1.6m
of which Land and buildings: -€63,066
Equity and liabilities
- Short-term financial debts -€730,377
down €730,377 (-74.6%), from €978,557 to €248,181
- Reserves +€245,946
up €245,946 (+65.2%), from €377,352 to €623,298
of which Distributable reserves: +€132,276
- Other debts -€148,855
down €148,855 (-15.2%), from €980,981 to €832,126
- Debts after one year -€109,630
down €109,630 (-15.4%), from €711,911 to €602,281
- Accrued charges and deferred income +€39,531
up €39,531 (+1,370%), from €2,886 to €42,418
Income statement
- Gross operating margin +€411,459
up €411,459 (+328%), from €125,636 to €537,094
- Financial charges +€109,021
up €109,021 (+266%), from €40,936 to €149,957
- Taxes +€77,864
up €77,864 (+23,637%), from €329 to €78,194
- Depreciation -€10,294
down €10,294 (-13.7%), from €74,950 to €64,656
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€1,570
Gross operating margin
+€411,459
Depreciation
+€10,294
Other operating charges
-€2,689
Financial income
-€3,116
Financial charges
-€109,021
Taxes
-€77,864
Result 2025
€230,631
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€1.2m
Investment
+€1,000
Financing
-€835,052
Cash 2024
€268,960
From operations (derived)
+€1.2m
Net result for the year
+€230,631
Depreciation
+€64,656
Stocks and contracts
+€1.1m
Receivables within one year
-€24,768
Smaller working-capital items
+€522
Trade debts
-€38,331
Other debts
-€148,855
Accrued charges and deferred income
+€39,531
Investment (derived)
+€1,000
Investment in fixed assets (net)
+€1,000
Financing
-€835,052
Debts after one year
-€109,630
Current portion of long-term debt
+€4,954
Short-term financial debts
-€730,377
Cash 2025
€666,692
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,531,405 | €2,780,869 | -€750,536 | -21.3% |
| Fixed assets | 21/28 | €1,671,828 | €1,606,171 | -€65,656 | -3.9% |
| Tangible fixed assets | 22/27 | €1,670,828 | €1,606,171 | -€64,656 | -3.9% |
| Land and buildings | 22 | €1,667,507 | €1,604,441 | -€63,066 | -3.8% |
| Plant, machinery and equipment | 23 | €281 | €0 | -€281 | -100% |
| Furniture and vehicles | 24 | €3,039 | €1,731 | -€1,309 | -43.1% |
| Financial fixed assets | 28 | €1,000 | €0 | -€1,000 | -100% |
| Current assets | 29/58 | €1,859,577 | €1,174,698 | -€684,879 | -36.8% |
| Stocks and contracts in progress | 3 | €1,524,944 | €416,547 | -€1.1m | -72.7% |
| Contracts in progress | 37 | €1,524,944 | €416,547 | -€1.1m | -72.7% |
| Amounts receivable within one year | 40/41 | €64,712 | €89,480 | +€24,768 | +38.3% |
| Trade receivables | 40 | €48,426 | €40,510 | -€7,916 | -16.3% |
| Other amounts receivable | 41 | €16,286 | €48,970 | +€32,684 | +201% |
| Cash at bank and in hand | 54/58 | €268,960 | €666,692 | +€397,731 | +148% |
| Deferred charges and accrued income | 490/1 | €962 | €1,979 | +€1,018 | +106% |
| Total equity and liabilities | 10/49 | €3,531,405 | €2,780,869 | -€750,536 | -21.3% |
| Equity | 10/15 | €709,167 | €939,798 | +€230,631 | +32.5% |
| Contributions | 10/11 | €316,500 | €316,500 | = | 0.0% |
| Reserves | 13 | €377,352 | €623,298 | +€245,946 | +65.2% |
| Tax-exempt reserves | 132 | - | €113,670 | +€113,670 | |
| Distributable reserves | 133 | €377,352 | €509,628 | +€132,276 | +35.1% |
| Profit (loss) carried forward | 14 | €15,314 | €0 | -€15,314 | -100% |
| Amounts payable | 17/49 | €2,822,238 | €1,841,071 | -€981,167 | -34.8% |
| Amounts payable after more than one year | 17 | €711,911 | €602,281 | -€109,630 | -15.4% |
| Financial debts | 170/4 | €711,911 | €602,281 | -€109,630 | -15.4% |
| Amounts payable within one year | 42/48 | €2,107,441 | €1,196,372 | -€911,068 | -43.2% |
| Current portion of amounts payable after more than one year | 42 | €104,676 | €109,630 | +€4,954 | +4.7% |
| Financial debts | 43 | €978,557 | €248,181 | -€730,377 | -74.6% |
| Credit institutions | 430/8 | €978,557 | €248,181 | -€730,377 | -74.6% |
| Trade debts | 44 | €39,034 | €703 | -€38,331 | -98.2% |
| Suppliers | 440/4 | €39,034 | €703 | -€38,331 | -98.2% |
| Taxes, remuneration and social security | 45 | €4,192 | €5,732 | +€1,540 | +36.7% |
| Taxes | 450/3 | €4,192 | €5,732 | +€1,540 | +36.7% |
| Other amounts payable | 47/48 | €980,981 | €832,126 | -€148,855 | -15.2% |
| Accrued charges and deferred income | 492/3 | €2,886 | €42,418 | +€39,531 | +1,370% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €74,950 | €64,656 | -€10,294 | -13.7% |
| Other operating charges | 640/8 | €11,349 | €14,038 | +€2,689 | +23.7% |
| Gross operating margin | 9900 | €125,636 | €537,094 | +€411,459 | +328% |
| Operating profit (loss) | 9901 | €39,337 | €458,400 | +€419,063 | +1,065% |
| Financial income | 75/76B | €3,498 | €381 | -€3,116 | -89.1% |
| Recurring financial income | 75 | €3,498 | €381 | -€3,116 | -89.1% |
| Financial charges | 65/66B | €40,936 | €149,957 | +€109,021 | +266% |
| Recurring financial charges | 65 | €40,936 | €149,957 | +€109,021 | +266% |
| Profit (loss) for the period before taxes | 9903 | €1,899 | €308,825 | +€306,926 | +16,160% |
| Income taxes | 67/77 | €329 | €78,194 | +€77,864 | +23,637% |
| Profit (loss) for the period | 9904 | €1,570 | €230,631 | +€229,062 | +14,591% |
| Transfer to tax-exempt reserves | 689 | - | €113,670 | +€113,670 | |
| Profit (loss) for the period to be appropriated | 9905 | €1,570 | €116,961 | +€115,392 | +7,351% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.